drugset / Trial / NCT05147727

Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects

NCT05147727

Phase 1 Completed 22 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

An open-label, fixed-sequence, drug-drug interaction study to evaluate the effects of fluconazole on the pharmacokinetics and safety of famitinib in healthy subjects.

Timeline

Start
2022-03-14
Primary completion
2022-05-02
Completion
2022-05-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Famitinib Small molecule
Subject Fluconazole Small molecule

Indications